Syrris’ Asia flow chemistry system joins select group of R&D 100 Award winners
10 July 2012 | By kdm communications limited
Syrris has won a prestigious 2012 R&D 100 Award for Asia...
List view / Grid view
News
Abbott announces new test for the management of patients with diabetes
More than 346 million people worldwide are living with diabetes, and the World Diabetes Foundation estimates that number will increase by nearly 27 percent by 2030. In order to help physicians appropriately monitor treatment efficacy for these patients, Abbott announced today CE Marking (Conformité Européenne) for the Abbott ARCHITECT HbA1c…
Boehringer Ingelheim pursuing health care innovation – new collaboration with Healthrageous, Inc
10 July 2012 | By Boehringer Ingelheim
Boehringer Ingelheim is concentrating on new business models...
Bristol-Myers Squibb Begins Tender Offer to Acquire Amylin Pharmaceuticals, Inc.
10 July 2012 | By Bristol-Myers Squibb Company
Bristol-Myers Squibb announced on Friday, June 29, 2012, its intent to acquire Amylin...
Lonza launches next generation GS Gene Expression System™
Lonza, a world leader in gene expression and biopharmaceutical development of protein therapeutics, announced today the launch of the new GS Xceed™ Gene Expression System.
Sanofi-aventis withdraws its marketing authorisation application for Mulsevo
9 July 2012 | By European Medicines Agency (EMA)
The EMA has been notified by Sanofi-aventis of its decision to withdraw its marketing authorisation application for Mulsevo...
B&W Tek launches new website with renewed focus on spectroscopy solutions
9 July 2012 | By B&W Tek
B&W Tek, Inc., is thrilled to introduce their exciting and intuitive new website...
Phenomenex UHPLC column protection system wins R&D 100 Award
9 July 2012 | By Phenomenex Inc
The SecurityGuard™ ULTRA UHPLC column protection system has been recognized as one of the top innovations of 2012...
Boehringer Ingelheim establishes translational research collaboration with Harvard University
9 July 2012 | By Boehringer Ingelheim
"We are very pleased to sponsor the joint research programs..."
Seven pharmaceutical companies join academic researchers to speed TB drug discovery
6 July 2012 | By Abbott
Groundbreaking partnership that aims to speed the discovery of essential new treatments...
Lilly obtains six months U.S. pediatric exclusivity for Cymbalta®
6 July 2012 | By Eli Lilly and Company
Eli Lilly and Company has met the United States FDA requirements for pediatric exclusivity for Cymbalta®...
AstraZeneca completes sale of Aptium Oncology assets
6 July 2012 | By AstraZeneca
AstraZeneca has completed the previously indicated sale of the assets of its subsidiary, Aptium Oncology...
Boehringer Ingelheim announces changes to Board of Managing Directors
5 July 2012 | By Boehringer Ingelheim
Joachim Hasenmaier to lead new Board Division Consumer Healthcare and Animal Health...
Amgen completes acquisition of KAI Pharmaceuticals
5 July 2012 | By Amgen
Amgen has announced the completion of the acquisition of KAI Pharmaceuticals, a privately held company based in South San Francisco...
Biogen Idec and SOBI initiate global clinical trials of long-lasting hemophilia A and B product candidates in children
5 July 2012 | By Biogen Idec
Biogen Idec and SOBI announced the initiation of two global pediatric clinical trials...
